Gene polymorphism of CYP2C subfamily and inter-individual differences in drug metabolism
Gene polymorphism of CYP2C subfamily and inter-individual differences in drug metabolism
批准号:
10672145
负责人:
CHIBA Kan
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
研究了154名日本人CYP2C18和CYP2C19突变等位基因的重合性。CYP2C18的突变等位基因为CYP2C18m1(T204A)和CYP2C18mFR(A-460T), CYP2C19的突变等位基因为CYP2C19m1(G689A)和CYP2C19m2(G636A)。结果表明,CYP2C18m1和CYP2C18mFR基因型分别与CYP2C19m2和CYP2C19m1基因型完全一致。这一发现表明,在本研究中检测的CYP2C18和CYP2C19突变至少在日本人群中彼此密切相关。我们还研究了酵母细胞中表达的CYP2C9野生型(CYP2C9- ile359)和突变型(CYP2C9- leu359)的7种代谢反应的动力学。对于所研究的所有底物的代谢,Leu变体的Vmax/Km值比野生型小。野生型与Leu变异的Vmax/Km差异在3.4 ~ 26.9倍之间。结果表明,Ile359Leu的改变降低了cyp2c9介导反应的催化活性,但活性降低的程度因底物而异。
英文摘要
The coincidence of mutant alleles of CYP2C18 and CYP2C19 was studied in 154 Japanese subjects. The mutant alleles of CYP2C18 were CYP2C18m1(T204A) and CYP2C18mFR(A-460T) and those of CYP2C19 were CYP2C19m1(G689A) and CYP2C19m2(G636A). The results indicated that genotypes of CYP2C18m1 and CYP2C18mFR are completely coincident with those of CYP2C19m2 and CYP2C19m1, respectively. The finding suggests that the mutations of CYP2C18 and CYP2C19 examined in the present study are very closely linked with each other at least in a Japanese population. We also studied the kinetics of seven metabolic reactions using wild-type (CYP2C9-Ile359) and mutant (CYP2C9-Leu359) of CYP2C9 expressed in yeast cells. For the metabolism of all the substrates studied, The Leu variant exhibited smaller Vmax/Km values than wild-type. The differences in Vmax/Km between wild-type and Leu variant varied from 3.4-fold to 26.9-fold. The result suggests that Ile359Leu changes decreases the catalytic activity of CYP2C9-mediated reactions although the extent of decrease in the activity varies between substrates.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kubota T,Hibi N,Chiba K: "Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population"Biochem Pharmacol. 55. 2039-2042 (1998)
Kubota T、Hibi N、Chiba K:“日本人群中 CYP2C18 和 CYP2C19 突变等位基因的连锁”Biochem Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takanashi K, Tainaka H, Kobayashi K, Yasumori T, Hosokawa M, Chiba K: "CYP2CIle359 and Leu359 variants: enzyme kinetics study seven substrates"Pharmacogenetics. 10. 95-104 (2000)
Takanashi K、Tainaka H、Kobayashi K、Yasumori T、Hosokawa M、Chiba K:“CYP2CIle359 和 Leu359 变体:酶动力学研究七种底物”药物遗传学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takanashi K, Taninaka H, Kobayashi K, Yasumori T, Hosokawa M, Chiba K: "CYP2C9Ile359 and Leu359 variants : enzyme kinetics study seven substrates."Pharmacogenetics. 10. 95-104 (2000)
Takanashi K、Taninaka H、Kobayashi K、Yasumori T、Hosokawa M、Chiba K:“CYP2C9Ile359 和 Leu359 变体:酶动力学研究七种底物。”药物遗传学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kubota, T, HIBI N, Chiba K: "Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population"Biochem Pharmacol. 55. 2039-2042 (1998)
Kubota, T, HIBI N, Chiba K:“日本人群中 CYP2C18 和 CYP2C19 突变等位基因的连锁”Biochem Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takanashi K,Tainaka H,Kobayashi K,Yasumori T,Hosokawa M,Chiba K: "CYP2C9Ile359 and Leu359 variants : enzyme kinetics study seven substrates"Pharmacogenetics. 10. 95-104 (2000)
Takanashi K、Tainaka H、Kobayashi K、Yasumori T、Hosokawa M、Chiba K:“CYP2C9Ile359 和 Leu359 变体:酶动力学研究七种底物”药物遗传学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Creation of CYP3A- and P-glycoprotein-humanized mouse and its application to the study of drug metabolism and disposition
-
批准号:21390040
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2009
-
负责人:CHIBA Kan
-
依托单位:
Identification of hepatic genes regulated in early phase of cholestasis by cDNA microarray analysis in rats
-
批准号:15390044
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.27万
-
财政年份:2003
-
负责人:CHIBA Kan
-
依托单位: